Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | W007026 | — |
This pharmacist reported that a 40 year old male patient received his first dose of Gardasil on 23-Feb-2024. His next doses were to be administered at 2 and 6 months but he did not get them. The pharmacist wondered if he has to restart his series.; This spontaneous report was received from a Pharmacist and refers to a 40-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 23-Feb-2024, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (dose, units and route of administration were not reported) lot #W007026, which was confirmed to be valid and the expiration date was verified to be 12-Apr-2024, for prophylaxis. It was reported that the patient's next doses were to be administered at 2 and 6 months but he did not get them. The pharmacist wondered if he had to restart his series (Inappropriate schedule of product administration).